| Names | |
|---|---|
| Preferred IUPAC name 2-(3-Chloro-2-methylanilino)pyridine-3-carboxylic acid | |
| Other names Clonixic acid; CBA 93626[1] | |
| Identifiers | |
3D model (JSmol) | |
| ChEBI |
|
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.037.921 |
| KEGG |
|
| UNII | |
| |
| |
| Properties | |
| C13H11ClN2O2 | |
| Molar mass | 262.69 g·mol−1 |
| Pharmacology | |
| per os | |
| Pharmacokinetics: | |
| Glucuronidation via UGT2B7 | |
| Legal status |
|
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Clonixin is anonsteroidal anti-inflammatory drug (NSAID). It also hasanalgesic,antipyretic, andplatelet-inhibitory actions. It is used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.

The glyceryl ester of clonixin, clonixeril, is also an NSAID. It was prepared by a somewhat roundabout method.

Clonixin was reacted withchloroacetonitrile andtriethylamine to give2. Heating withpotassium carbonate andglycerol acetonide displaced theactivating group to produce ester3, which was deblocked inacetic acid to produce clonixeril (4).
Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byexpanding it. |